Skip to main content
. 2017 Jun 28;10:205. doi: 10.3389/fnmol.2017.00205

Figure 2.

Figure 2

Attenuated acute itch in Tlx3cko mice. The acute itch responses evoked by distinct pruritogens were examined in both Tlx3cko and control mice (A–D). (A) Decreased scratch bouts evoked by Compound48/80 (20 μg) in Tlx3cko mice (control, 145 ± 9, n = 6; Tlx3cko, 48 ± 7, n = 6; p < 0.0001). (B) Decreased scratch bouts evoked by Chloroquine (200 μg) in Tlx3cko mice (control, 120 ± 20, n = 10; Tlx3cko, 24 ± 9, n = 6; p = 0.0037). (C) Decreased scratch bouts evoked by α-Me-5-HT (30 μg) in Tlx3cko mice (control, 138 ± 6, n = 6; Tlx3cko, 42 ± 13, n = 6; p = 0.0002). (D) Decreased scratch bouts evoked by SLIGRL-NH2 (100 nmol) in Tlx3cko mice (control, 76 ± 11, n = 6; Tlx3cko, 17 ± 3, n = 7; p = 0.0003). **, ***Indicate p < 0.01, p < 0.001, respectively.